Retinitis Pigmentosa

Showing 1 - 25 of 178

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glaucoma, Age-related Macular Degeneration, Retinitis Pigmentosa Trial in Guangzhou (New head-mounted visual aids)

Not yet recruiting
  • Glaucoma
  • +3 more
  • New head-mounted visual aids
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Oct 7, 2023

Study in Subjects Who Received vMCO-I Administered Via

Enrolling by invitation
  • Retinitis Pigmentosa
  • +2 more
  • Gene Therapy product:vMCO-I
  • Cuttack, Odisha, India
    JPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 26, 2023

Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal

Not yet recruiting
  • Age-Related Macular Degeneration
  • +2 more
  • Non-invasive ultrasound retinal stimulation Device
  • (no location specified)
Jun 19, 2023

Retinitis Pigmentosa Trial (1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CM)

Not yet recruiting
  • Retinitis Pigmentosa
  • 1.5 x 10^6 UC-MSC + CM
  • 5 x 10^6 UC-MSC + CM
  • (no location specified)
Jun 11, 2023

Retinitis Pigmentosa Trial in Shanghai (AuTNA I)

Recruiting
  • Retinitis Pigmentosa
  • AuTNA I
  • Shanghai, Shanghai, China
    Chunhui Jiang
May 2, 2023

Retinitis Pigmentosa Patients

Not yet recruiting
  • Retinitis Pigmentosa
    • (no location specified)
    Apr 28, 2023

    Retinitis Pigmentosa Trial (2C-QD, Sham 2C-QD)

    Not yet recruiting
    • Retinitis Pigmentosa
    • 2C-QD
    • (no location specified)
    Apr 24, 2023

    Assess the Reliability and Validity of the MLYMT

    Recruiting
    • Retinitis Pigmentosa
    • Retinal Dystrophy
    • Observational
    • Beverly Hills, California
    • +6 more
    Apr 18, 2023

    Study of BEST1 Vitelliform Macular Dystrophy

    Recruiting
    • Best Vitelliform Macular Dystrophy
    • Retinitis Pigmentosa
    • Natural History Study
    • New York, New York
    • +2 more
    Mar 30, 2023

    Retinitis Pigmentosa Trial (ZVS203e)

    Not yet recruiting
    • Retinitis Pigmentosa
    • (no location specified)
    Mar 27, 2023

    Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)

    Completed
    • Retinitis Pigmentosa
    • Wharton's jelly derived mesenchymal stemcells
    • Magnovision
    • Ankara, Gölbaşı, Turkey
    • +2 more
    Mar 23, 2023

    Inherited Retinal Dystrophies Using Whole Genome Sequencing and

    Recruiting
    • Inherited Retinal Dystrophy
    • +2 more
    • whole genome sequencing
    • Rome, Italy
      Istituto Superiore di Sanità-Dpt. Oncology and Molecular Medicin
    Mar 30, 2023

    UC-MSC Transplantation in Patients With Retinitis Pigmentosa

    Enrolling by invitation
    • Retinitis Pigmentosa
    • Conditioned Medium (CM)
    • Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
    • Jakarta, DKI Jakarta, Indonesia
    • +1 more
    Mar 14, 2023

    Retinitis Pigmentosa Trial in Pittsburgh, Paris (SPVN06)

    Not yet recruiting
    • Retinitis Pigmentosa
    • Pittsburgh, Pennsylvania
    • +1 more
    Feb 17, 2023

    Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)

    Completed
    • Retinitis Pigmentosa
    • Stem Cell Transplant
    • Stem cell implantation
    • Istanbul, Turkey
      Acıbadem University
    Jan 25, 2023

    Study of Retinal Dystrophies Associated With Rare

    Active, not recruiting
    • Inherited Retinal Degeneration
    • Retinitis Pigmentosa
      • Phoenix, Arizona
      • +23 more
      Jan 24, 2023

      Retinitis Pigmentosa, Retinitis Pigmentosa Syndrome Trial in United States (EA-2353)

      Recruiting
      • Retinitis Pigmentosa
      • Retinitis Pigmentosa Syndrome
      • Miami, Florida
      • +5 more
      Jan 24, 2023

      Cell Collection to Study Eye Diseases

      Recruiting
      • Retinal Disease
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Retinitis Pigmentosa Trial in Tel Hashomer (Alga Dunaliella Bardawil, Placebo (starch))

        Active, not recruiting
        • Retinitis Pigmentosa
        • Alga Dunaliella Bardawil
        • Placebo (starch)
        • Tel Hashomer, Israel
          Sheba Medical Center
        Jan 15, 2023

        Objective Perimetry Using Chromatic Multifocal Pupillometer

        Recruiting
        • Retinal Dystrophies
        • +2 more
          • Tel HaShomer, Israel
            Sheba Medical Center
          Jan 15, 2023

          Retinitis Pigmentosa Trial in Paris (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE))

          Active, not recruiting
          • Retinitis Pigmentosa
          • Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)
          • Paris, France
            •Centre Hospitalier National d'Ophtalmologie (CHNO) des Quinze-V
          Jan 11, 2023

          Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for

          Terminated
          • Retinitis Pigmentosa
          • Usher Syndrome Type 2
          • RNA antisense oligonucleotide for intravitreal injection
          • Boston, Massachusetts
          • +6 more
          Dec 12, 2022

          Retinitis Pigmentosa Trial (KIO-301)

          Recruiting
          • Retinitis Pigmentosa
          • Adelaide, South Australia, Australia
            Royal Adeliade Hospital
          Dec 22, 2022

          Retinitis Pigmentosa Trial in Tuebingen (subretinal injection of rAAV.hPDE6A)

          Active, not recruiting
          • Retinitis Pigmentosa
          • subretinal injection of rAAV.hPDE6A
          • Tuebingen, Germany
            Universitätsklinikum Tübingen, Department für Augenheilkunde
          Dec 7, 2022

          Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

          Recruiting
          • Retinal Disease
          • +17 more
          • Arm 1
          • Westport, Connecticut
          • +2 more
          Nov 25, 2022